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Retrospective epidemiological studies showan inverse correlationbetween susceptibility to Parkinson’s disease and aperson’s history of
tobacco use. Animal model studies suggest nicotine as a neuroprotective agent and nicotinic acetylcholine (ACh) receptors (nAChRs) as
targets for neuroprotection, but the underlying neuroprotective mechanism(s) are unknown. We cultured mouse ventral midbrain
neurons for 3 weeks. Ten to 20% of neurons were dopaminergic (DA), revealed by tyrosine hydroxylase (TH) immunoreactivity. We
evoked mild endoplasmic reticulum (ER) stress with tunicamycin (Tu), producing modest increases in the level of nuclear ATF6, phos-
phorylated eukaryotic initiation factor 2, nuclearXBP1, and the downstreamproapoptotic effector nuclear C/EBPhomologous protein.
We incubated cultures for 2 weeks with 200 nM nicotine, the approximate steady-state concentration between cigarette smoking or
vaping, or during nicotine patch use. Nicotine incubation suppressed Tu-induced ER stress and the unfolded protein response (UPR).
Study of mice with fluorescent nAChR subunits showed that the cultured TH neurons displayed 4, 6, and 3 nAChR subunit
expression andACh-evoked currents. Gene expressionprofile in cultures fromTH-eGFPmice showed that theTHneurons also express
several other genes associated with DA release. Nicotine also upregulated ACh-induced currents in DA neurons by 2.5-fold. Thus,
nicotine, at a concentration too low to activate an appreciable fraction of plasma membrane nAChRs, induces two sequelae of pharma-
cological chaperoning in the ER: UPR suppression and nAChR upregulation. Therefore, one mechanism of neuroprotection by nicotine
is pharmacological chaperoning, leading to UPR suppression. Measuring this pathway may help in assessing neuroprotection.
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Introduction
Dopaminergic (DA) neurons are subjected to Ca2 influx and to
potentially toxic byproducts of dopamine metabolism that can
affect proteostasis (Ahmadi et al., 2008; Miyazaki and Asanuma,
2009; Surmeier et al., 2011). Under normal circumstances, in-
traorganelle sensors for unfolded or misfolded proteins activate
unfolded protein responses (UPRs): homeostatic, adaptive, and
compensatory pathways transiently reprogram gene activation,
organelle physiology, and catabolic processes. When physiologi-
cal stresses occur in the context of pathophysiological cellular
processes such as aberrant protein folding or chronic exposure to
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Significance Statement
Parkinson’s disease (PD) cannot yet be cured or prevented.However,many retrospective epidemiological studies reveal that PD is
diagnosed less frequently in tobaccousers. Existingprogramsattempting todevelopnicotinicdrugs thatmight exert this apparent
neuroprotective effect are askingwhether agonists, antagonists, partial agonists, or channel blockers show themost promise. The
underlying logic resembles thepreviousdevelopmentof varenicline for smoking cessation.Westudiedwhether, andhow,nicotine
produces neuroprotective effects in cultured dopaminergic neurons, an experimentally tractable, mechanistically revealing neu-
ronal system.We show that nicotine, operating via nicotinic receptors, does protect these neurons against endoplasmic reticulum
stress. However, the mechanism is probably “inside-out”: pharmacological chaperoning in the endoplasmic reticulum. This
cellular-level insight could help to guide neuroprotective strategies.
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environmental toxins, DA neurons display sustained UPR (Mer-
cado et al., 2013). Unmitigated and maintained UPR activates a
proapoptotic effector, C/EBP homologous protein (CHOP). Sev-
eral authors suggest that CHOP partially underlies DA cell death
and the development of Parkinson’s disease (PD; Zinszner et al.,
1998; Marciniak et al., 2004; Silva et al., 2005; Galehdar et al.,
2010; Mercado et al., 2013).
More than 50 retrospective epidemiological studies since 1959
demonstrated an inverse correlation between a person’s history
of tobacco use and his or her risk of developing PD. Tobacco use
decreases the risk by roughly twofold (Herna´n et al., 2002; Tanner
et al., 2002; Ritz et al., 2007; Quik andWonnacott, 2011). On the
one hand, this correlation could arise from “inverse causality”: in
a person with early-stage, preclinical damage to DA neurons,
nicotine may stimulate the DA reward pathway less strongly. On
the other hand, a genuine neuroprotective effect could appear
because decades-long, cumulative neuropathology would be
minimized by a maintained protective effect of tobacco. Because
there will never be a medical justification for using smoked or
smoke-cured tobacco, it is important to understand the mecha-
nism of the apparent or real neuroprotective effect.
Nicotine, the addictive component of tobacco, exerts neuro-
protection in in vivo models of Parkinsonism (Maggio et al.,
1998; Costa et al., 2001; Ryan et al., 2001; Quik and Wonnacott,
2011). Several mechanisms now allow humans to ingest or con-
sume nearly pure nicotine without the harmful effects of tobacco
smoke. Thesemethods include nicotine gum, inhalers, electronic
nicotine delivery systems (“e-cigarettes”), and nicotine patches.
How can one design a neuroprotective dose regime involving
nicotine? Some, but not all, previous clinical trials with nicotine
patches show an attenuation of PD symptoms (Fagerstrom et al.,
1994; Kelton et al., 2000; Mitsuoka et al., 2002; Villafane et al.,
2007), and another, more ambitious, trial is under way (https://
clinicaltrials.gov/show/NCT01560754). These trials all tacitly as-
sume that neuroprotective dosing of nicotine would operate by
the same mechanism as the protection against nicotine with-
drawal—that is, by achieving the highest tolerable dose of nico-
tine, to activate or desensitize plasma membrane nicotinic
acetylcholine receptors (nAChRs).
However, since 2005, evidence has accumulated that nicotine,
when chronically applied at comparatively low doses, acts as a
pharmacological chaperone on nAChRs in the endoplasmic
reticulum (ER). Activation and desensitization of nAChRs chan-
nels is not involved (Henderson and Lester 2015). In overexpres-
sion systems, the consequences of pharmacological chaperoning
include suppression of ER stress and the UPR (Srinivasan et al.,
2012). Another consequence of pharmacological chaperoning is
the classically described upregulation of nAChRs (Marks et al.,
1985; Schwartz and Kellar, 1985; Henderson and Lester 2015).
To further understand possible neuroprotective mechanisms
of nicotine, this study develops and exploits a cultured model for
nicotine neuroprotection: endogenously expressed nAChRs in
DA neurons. Our experimental strategy involves (1) mild ER
stress rather than frank neuronal death and (2) “prolonged” (2
weeks) exposure to concentrations of nicotine attained in blood
during smoking (“smoking-relevant” doses). Nicotine attenuates
the UPR and prevents CHOP activation following exposure to
low doses of the ER stress inducer tunicamycin (Tu). Nicotine
neuroprotection can thus be detected at a rather early stage of
stress in a reduced system.We show that in DA neurons, nicotine
also upregulates natively expressed nAChRs—a hallmark of
pharmacological chaperoning. In addition to providing a mech-
anism for neuroprotection by nicotine itself, our results suggest
strategies for discovering novel drugs that might forestall PD.
Materials andMethods
Cell culture reagents and chemicals. Neurobasal medium with phenol
red, B27 supplement, GlutaMAX, and Hyclone equine serum were
purchased from Invitrogen. L-ascorbic acid, ()-nicotine, poly-L-
ornithine (P4957), laminin (L2020), papain, and DNase were purchased
from Sigma-Aldrich. Tu was purchased from Tocris Bioscience. For
long-term cultures, 35mmuncoated glass-bottom imaging dishes with a
14 mm diameter of the imaging area and 0.19 mm coverslip thickness
were purchased from MatTek. Cell culture plasticware was purchased
from Grenier Bio-One.
Mice. All experiments were conducted in accordance with the guide-
lines for care and use of animals provided by the National Institutes of
Health, and protocols were approved by the Institutional Animal Care
and Use Committee at the California Institute of Technology. C57BL/6
mice used for primary cultures were purchased from the Jackson Labo-
ratory. The 3-GFP nAChR knock-in mouse strain has been described
previously (Shih et al., 2014). TheGene ExpressionNervous SystemAtlas
(GENSAT) TH-eGFP strain (Gong et al., 2003) used for RNA-
sequencing (RNA-Seq) studies was purchased from the Mutant Mouse
Regional Resource Center (Chapel Hill, NC). The 6-eGFP bacterial
artificial chromosome (BAC) transgenic mice used in this study possess
six copies of the 6-eGFP BAC (Mackey et al., 2012).
Construction of4-mCherry knock-in mice.The4-mCherry knock-in
mouse was constructed in a manner similar to the previously described
4-YFP knock-in mouse (Nashmi et al., 2007). Briefly, a 4-mCherry
knock-in construct was linearized and electroporated into CJ7 mouse
embryonic stem (ES) cells. Recombinant clones were selected with G418
and screened for the presence of the neo cassette andmCherry insert by a
combination of PCR and automated sequence analysis. To confirm the
correct position of the homologous recombination of the targeting con-
struct within the genome and the insertion of mCherry and neo cassette,
ES cells were screened by PCR and sequencing. Karyotype analysis was
used to assess chromosome number. Positive clones with the highest
percentage of correct number of chromosomes were selected for a sub-
sequent round of electroporation. Clones were injected into C57BL/6
blastocysts to create chimeras. Chimeras were mated with wild-type an-
imals, and germline transmission was established. Founder mice were
mated, and colonies with 4-mCherry homozygous mice were estab-
lished. For timed mating of 4-mCherry homozygous mice, genotypes
were assessed by PCR analysis of tail DNA.
Mouse ventral midbrain dopaminergic cultures. Ventral midbrain cul-
tures were obtained from embryonic day 14 (E14) mouse embryos of
either sex. Embryos were extracted from timed pregnantmice.Micewere
decapitated and the ventral midbrain dissected out using a standard
method (Pruszak et al., 2009). Following digestion with papain (15 min
at 37°C), cells were separated by DNase treatment and mechanical tritu-
ration. A total of 100,000 cells, including neurons and glia, were plated in
the center of poly-L-ornithine- and laminin-coated 35 mm glass-bottom
imaging dishes. After plating, dishes were placed in a 37°C incubator
supplemented with 5% CO2 for 1 h, followed by addition of 3 ml of
Neurobasal medium supplemented with B27, GlutaMAX, 1% Hyclone
equine serum, and 100 M ascorbic acid to each dish. The culture me-
dium was exchanged at 3 d intervals and no antibiotics were used. With
thismethod, we couldmaintain cultures of ventral midbrain neurons for
3 months containing 10% tyrosine hydroxylase positive (TH) neu-
rons. Assays described in this study were performed at 3 weeks in culture.
Nicotine (200 nM) was added to the culture for 2 weeks from days 7–21
after initial plating and was replenished every 3 d.
Mouse neuroblastoma-2a cell culture. Neuroblastoma-2a (Neuro-2a)
cells were cultured using standard techniques (Xiao et al., 2011; Sriniva-
san et al., 2012; Henderson et al., 2014). Cells were plated by adding
90,000 cells to poly-D-lysine-coated 35 mm glass-bottom imaging dishes
(MatTek) and cultured in a humidified incubator (37°C, 95% air, 5%
CO2). Cells were transfected with 500 ng ATF6-eGFP plasmid mixed
with 250 l of Opti-MEM. Lipofectamine-2000 was separately added to
250 l of Opti-MEM. After 5 min at 24°C, DNA and Lipofectamine
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solutions were mixed together and incubated for 25 min at 24°C. The
solutions were then added to preplated Neuro-2a cells and incubated for
24 h. After 24 h, the Opti-MEM was removed and replaced with growth
medium. One hundred nanomolar filter-sterilized nicotine or Tu was
added during transfection for 48 h treatment (Srinivasan et al., 2012).
Imaging experiments were performed in live Neuro-2a cells at 37°C in a
stage-mounted culture dish incubator (Warner Instruments). Confocal
imaging was conducted as described below (Confocal imaging and anal-
ysis). Before an imaging session, cell culture medium was replaced with
extracellular solution, pH 7.4. eGFP was excited at 488 nm. For quanti-
fication, regions of interest (ROIs) were demarcated manually using Im-
ageJ (NIH; http://rsb.info.nih.gov/ij/).
Immunostaining. Neuron–glia cultures were fixed with 4% para-
formaldehyde for 20 min at room temperature (RT), washed two
times with PBS, and incubated with 0.01% Triton X-100 for 5 min at
RT. Following two washes with PBS, cells were incubated in 10%
donkey serum (DS) for 30 min at RT, followed by incubation with the
primary antibody in 1% DS for 1 h at RT and constant agitation. Cells
were washed three times with PBS, incubated with the secondary
antibody diluted in 1% DS for 1 h at RT with constant agitation, and
washed three times with PBS. In the case of double labeling, cells were
first stained with the UPRmarker or mCherry primary and secondary
antibodies, followed by the TH primary and secondary antibodies.
TH and GFP antibodies were counterstained with Alexa 488 second-
ary, whereas an Alexa 555 secondary antibody was used to counter-
stain mCherry and UPR markers.
Fluorescence and bright-field images of ventral midbrain neuron–glia
cultures in Figure 2A were obtained with an IX81 Olympus inverted
fluorescencemicroscope equippedwith an Andor EMCCD camera and a
20 objective.
Antibody validation. Primary antibody specificity is a crucial method-
ological issue in immunocytochemical experiments.Wehave notworked
previously with CHOP antibodies. Many commercially available CHOP
antibodies fail evaluations for specificity, as discovered by Haataja et al.
(2008). Haataja et al. (2008) recommended verifying that a known in-
ducer of ER stress, such as Tu, does increase the level of nuclear CHOP.
We therefore performed pilot experiments with a CHOP antibody, Santa
Cruz Biotechnology sc-575 (1:250 dilution), also validated by Haataja et
al. (2008). After treatment with Tu (3 M, 20 h), we found robust in-
creases in nuclear CHOP, with more modest increases in cytoplasmic
CHOP (Fig. 1A). This reassured us that the CHOP antibody does have
the required characteristics.
We previously validated the antibodies for ATF6 (ab11909; Abcam;
Srinivasan et al., 2012), GFP (A11122; Invitrogen; Henderson et al.,
2014), phosphorylated eukaryotic initiation factor 2 (p-eIF2; 5324P;
Cell Signaling Technology; Srinivasan et al., 2012), and total eIF2
(3597S; Cell Signaling Technology; Srinivasan et al., 2012). In the present
study, the mCherry antibody (632392; Clontech) showed no signal in
mice lacking mCherry-labeled 4 subunits (see Fig. 5C), validating this
antibody.
We also confirmed that the antibodies for the three ER stress markers
(p-EIF2, XBP1, ATF6, and CHOP) gave robust signals in immunohis-
tochemistry onDA (TH) neurons in adult mouse substantia nigra pars
compacta (Henley et al., 2013). Figure 1B shows that all TH neurons in
adult substantia nigra pars compacta display immunostaining for ATF6.
These data eliminate the admittedly unlikely possibility that the signals in
cultured neurons are tissue culture artifacts.
We did not independently validate the TH antibody (ab1542; Mil-
lipore, 1:1000 dilution) or the XBP1 antibody (sc-7160; Santa Cruz
Biotechnology). Secondary antibodies used in this study were goat
anti-rabbit Alexa 555 (catalog #A21428; Invitrogen), goat anti-rabbit
Alexa 488 (catalog #A11034; Invitrogen), donkey anti-sheep Alexa 488
(catalog #A11015; Invitrogen), and donkey anti-mouse Alexa 555 (cata-
log #A31570; Invitrogen), and were applied at a 1:2000 dilution.
Confocal imaging and analysis. Neurons were observed with a Nikon
Eclipse C1si laser scanning confocalmicroscope equippedwith a 63 1.4
numerical apertureVCPlanApo oil objective and a 32-anode photomul-
tiplier array. TH-labeled neurons were excited at 488 nm and focused to
a plane where the nucleus was largest and sharply demarcated. Alexa 488
and Alexa 555 fluorescence signals were acquired from 20 to 50 cells per
dish following sequential excitation with 488 nm and 561 nm laser lines,
respectively. Full emission spectra were acquired in 5 nm bins between
470 and 620 nm, and the signal of each fluorophorewas linearly unmixed
from the raw spectral image using reference spectra from unlabeled con-
trol neurons and neurons labeled with either Alexa 488 or Alexa 555.
Image analysis used ImageJ version 1.46 or later (Abramoff et al.,
2004). TH-labeled (Alexa 488) fluorescence was used to manually de-
marcate cytoplasmic ROIs using the ImageJ polygon drawing tool. The
Figure 1. Validation of antibodies. A, CHOP antibody staining inWTmouse ventral midbrain cultured cells that are also positive for TH (data not shown). Left, No drug. Right, Twenty hours in 3
M Tu. The left and right graphs show the nuclear and cytoplasmic CHOP intensity, respectively.B, ATF6 antibody staining in slices from adult mouse substantia nigra. Double stainingwith anti-TH
and anti-ATF6 shows that all DA neurons also stain for ATF6.
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absence of TH-stained fluorescence within the cell was used to manually
demarcate nuclear ROIs. This process was completed individually for all
imaged neurons. For every TH-labeled (Alexa 488) neuron, a UPR
marker (CHOP, ATF6, etc.) was labeled with Alexa 555 fluorescence.
Cytoplasmic and nuclear ROIs selected fromTH labeling were applied to
the Alexa 555 image of the same neuron. The ROIs were then used to
calculate the UPR marker intensity as a function of Alexa 555 fluores-
cence. TheUPRmarkermean intensity was then normalized to themean
intensity of the non-nicotine control neurons that were acquired during
the same imaging session.
Single cell RNA-Seq library construction from TH-eGFP mice. Ventral
midbrain cultures from TH-eGFP cultures were imaged on a wide-field
fluorescence microscope as described previously (Henley et al., 2013).
Single cell RNA-Seq libraries were generated as described previously
(Henley et al., 2013).
Electrophysiology. Glass coverslips with neuron–glia cultures were
detached from imaging dishes and cut into two equal pieces, and one
piece was placed in the recording chamber of an upright microscope
(BX50WI; Olympus). Nicotine-free solutions were present 1 h be-
fore recordings. Electrophysiological signals were recorded from vi-
sually identified neurons with a MultiClamp 700B amplifier
(Molecular Devices), a Digidata 1322 analog-to-digital converter
(Molecular Devices), and pClamp 9.2 software (Molecular Devices).
Patch pipettes were filled with solution containing the following (in
mM): 135 K gluconate, 5 KCl, 5 EGTA, 0.5 CaCl2, 10 HEPES, 2 Mg-
ATP, and 0.1 GTP (pH adjusted to 7.2 with Tris-base, osmolarity was
adjusted to 280–300 mOsm with sucrose). The resistance of patch
pipettes was 4–8M. Junction potential was nulled just before form-
ing a gigaseal. Series resistance was monitored without compensation
throughout the experiment. Data were discarded if the series resis-
tance (10–25 M) changed by 20% during recordings. All record-
ings were done at room temperature. After achieving a gigaseal, gentle
suction was used to achieve whole-cell configuration. The neuron was
current clamped at 0 pA to record spontaneous action potentials
(APs), and then voltage clamped at 50 mV and subjected to step
hyperpolarizing test pulses at 20 mV increments to measure the pres-
ence or absence of Ih. Images of some recorded neurons were captured
using a Hamamatsu Orca 03G digital CCD camera (see Fig. 8).
To elicit ACh responses, 300 M ACh was dissolved in extracellular
solution containing (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10
HEPES, and 10 glucose (320 mOsm, pH set to 7.3 with Tris-base) and
puffed (0.2 s, 20 psi) onto voltage-clamped neurons (holding poten-
tial, 50 mV). Data were sampled at 10 kHz. For traces like those in
Figure 9, data were additionally filtered at 100 Hz. To avoid receptor
desensitization by repetitive ACh application, we applied ACh at 3
min intervals and continually perfused the recording chamber with
extracellular solution (Tapper et al., 2004; Xiao et al., 2009).
Statistical analysis. Data were analyzed and graphs generated using
Origin, version 7 (OriginLab), and they are presented as mean  SEM,
where n represents the number of cells studied. The statistical signifi-
cance of differences was evaluated using a Student’s t test (without cor-
rection for multiple comparisons) with confidence levels of p 	 0.001,
p	 0.01, p	 0.05, and p 0.05 (not significant). The data in Figure
6 were analyzed with a one-way ANOVA analysis with Tukey
comparisons.
Results
Culture and characterization of mouse DA neurons
To study nicotine neuroprotection in a system that emphasizes
cell-delimited rather than possible circuit-based influences of
chronic exposure to nicotine, we established procedures for the
long-term primary culture of mouse ventral midbrain neurons
(see Materials and Methods). Our 3-week-old neuron–glia ven-
tral midbrain cultures consisted of a glial cell monolayer and
midbrain neurons (Fig. 2). Ten percent or more of the neurons
were TH with neurites ranging from 100 to 200 m in length
(Fig. 2).
Figure 2. Cultured mouse DA neurons. A, Bright-field and TH-immunostained neurons from a 3-week-old WT mouse ventral midbrain culture. Left to right, Bright-field image of neurons
(indicated by white arrows) growing on a glial cell monolayer, TH immunostaining of a subset of the neurons, the same image showing the extent of TH processes, and a merge of TH
immunostainingwith the bright-field image.B, At highermagnification, a flattened confocal stack of a TH-stainedneuron. Left, Face on. Right, Side view. The processes are restricted to a plane near
the coverslip and probably interdigitate with the glial cell monolayer.
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Chronic nicotine exposure suppresses upregulation and
nuclear translocation of CHOP in DA neurons
We assessed the effects of chronic nicotine exposure on the pro-
apoptotic effector, CHOP. WT DA neurons were coimmunos-
tained with TH and CHOP antibodies. TH staining was used as a
visual guide to manually demarcate the nuclear and cytoplasmic
compartments of TH-positive DA neurons, and CHOP fluores-
cence was separately quantified in the nuclear or cytoplasmic
ROIs of untreated or nicotine-treated DA neurons (200 nM nic-
otine from 7 to 21 d in culture).
Untreated DA neurons showed uniform CHOP fluorescence
throughout the cell (Fig. 3A, left three panels), and exposure to nic-
otine alone did not alter CHOP intensity in either the nucleus or the
cytoplasm (Fig. 3B). We induced prolonged and mild ER stress by
incubating DA cultures with low doses of the known ER stress in-
ducer, Tu (50 or 150 nM for 72 h). Fifty nanomolar Tu caused a
significant 1.8-fold increase of CHOP fluorescence in the nucleus of
DA neurons and a small but significant increase in cytoplasmic
CHOP(Fig. 3C). Pretreatmentwithnicotine (200nM, from7 to21d
in culture) significantly reduced nuclear and cytoplasmic CHOP
fluorescence to levels indistinguishable from baseline (Fig. 3C).
At a higher concentration of Tu (150 nM), nicotine only par-
tially suppressed CHOP elevation. Tu caused a significant 2.8-
fold increase in nuclear CHOP and an 1.8-fold increase in
cytoplasmic CHOP (Fig. 3A, right three panels, C). Nicotine ex-
posure (200 nM, 7 to 21 d in culture) significantly reduced CHOP
Figure 3. Nicotine inhibits Tu-induced upregulation and nuclear translocation of CHOP in cultured DA neurons.A, Representative confocal images of DMSO-treated (three left panels) and 150 nM
Tu-treated (three right panels) DA neurons. TH, CHOP staining, and a merged image are shown in each case. B, Normalized baseline CHOP fluorescence with and without nicotine treatment. C,
Normalized CHOP fluorescence following treatmentwith 50 or 150 nM Tuwith andwithout nicotine pretreatment.D, Normalized CHOP fluorescence following treatmentwith 50 nM Tu for 48 hwith
and without nicotine (Nic) and mecamylamine (Mec) pretreatment. E, Normalized CHOP fluorescence following treatment with 50 nM Tu for 72 h with and without nicotine and mecamylamine
pretreatment. For all graphs, drugs applied and subcellular compartments (nucleus or cytoplasm) are shown on the x-axis. Nicotine (200 nM) andmecamylamine (5M)were applied from 7 to 21 d
in culture; Tuwasapplied for 72h. Thenumberofneurons imaged is shown ineachbar in thegraphs. Error bars areSEM,andpvalues arebasedonStudent’s two-tailed t testwithunequal variance.
*p	 0.05; **p	 0.01; ***p	 0.001. NS, Not significant.
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levels in the nucleus and in the cytoplasm, but to levels that were
elevated with respect to baseline (Fig. 3C).
To test whether the effect of nicotine on CHOP depended on
the activation of surface nAChRs, DA cultures were pretreated
with either nicotine (200 nM from7 to 21 d in culture) or nicotine
and the nonselective nAChR antagonist mecamylamine (5 M
from7 to 21 d in culture), andmild ER stresswas inducedwithTu
(50 nM for 48 or 72 h). Tu (50 nM) increased nuclear CHOP
fluorescence by 1.8-fold after 48 h (Fig. 3D) and by 3.1-fold after
72 h (E) of exposure. As expected, Tu also induced a small but
significant increase in cytoplasmic CHOP fluorescence at 48 and
72 h time points (Fig. 3D,E), and nicotine significantly attenu-
ated Tu-induced CHOP upregulation in the nucleus and cyto-
plasm of DA neurons (Fig. 3D,E). When compared to cells
treated with nicotine alone, cotreatment of DA cultures with
mecamylamine (5M from 7 to 21 d in culture) and nicotine did
not affect CHOP fluorescence in the nucleus or cytoplasm fol-
lowing exposure to 50 nMTu for 48 or 72 h (Fig. 3D,E). In control
experiments, pretreatment of DA cultures with mecamylamine
alone (5 M from 7 to 21 d in culture) did not attenuate Tu-
induced CHOP upregulation in the cytoplasm or the nucleus
(Fig. 3E).
These data demonstrate that nicotine attenuates CHOP up-
regulation and nuclear translocation in cultured DA neurons.
This effect occurs at a smoking-relevant nicotine concentration
that activates few plasma membrane nAChRs, as well as in the
presence of a nAChR channel blocker.
Chronic nicotine suppresses nuclear translocation of XBP1
and ATF6 in stressed DA neurons
Since CHOP is downstream of UPR signaling pathways, we as-
sessed three signaling arms of the UPR triggered by ER resident
stress sensors (Figs. 4, 5). These arms are (1) XBP1, which lies
downstream of the ER stress sensor inositol-requiring enzyme 1
(IRE1); (2) ATF6; and (3) the protein kinase RNA-like endoplas-
mic reticulum kinase (PERK) pathway. The PERK pathway leads
to eIF2 phosphorylation.
DAneuronswere costainedwith THand either XBP1 orATF6
antibodies, and nuclear and cytoplasmic fluorescence were quan-
tified separately. Under baseline conditions, we observed a uni-
form fluorescence of XBP1 in the nucleus and cytoplasm of DA
neurons (Fig. 4A). XBP1 fluorescence intensity in the nucleus and
cytoplasm were unaffected following chronic nicotine treatment
(200 nM from 7 to 21 d in culture; Fig. 4B). Treatment with
low-dose Tu (50 nM, 48 h) caused an 1.8-fold increase in nu-
clear XBP1 compared to untreated controls (Fig. 4A,C) and a
small but significant increase in cytoplasmic XBP1 (Fig. 4C). Pre-
treatment with nicotine (200 nM from 7 to 21 d) inhibited the
Tu-induced increase in nuclear XBP1 (Fig. 4C), but had no effect
on cytoplasmic XBP1 (Fig. 4C).
Figure4. Nicotine inhibits Tu-inducedupregulationandnuclear translocationof XBP1andATF6 in culturedDAneurons.A, Representative confocal imagesofDAneurons stainedwitheither XBP1
or ATF6 plus either DMSO or Tu. The UPRmarker is indicated for each row, and column labels indicate images with TH staining andmerged images. B, Normalized baseline XBP1 fluorescence with
and without nicotine treatment. C, Normalized XBP1 fluorescence following treatment with 50 nM Tu, with and without nicotine pretreatment. D, Normalized baseline ATF6 fluorescence with and
without nicotine treatment. E, Normalized ATF6 fluorescence following treatment with 50 nM Tu for 48 h, with and without nicotine pretreatment. F, Normalized ATF6 fluorescence following
treatmentwith 1M Tu for 24 h, with andwithout nicotine pretreatment. For all graphs, drugs applied and subcellular compartments (nucleus or cytoplasm) are shown on the x-axis. Nicotine (200
nM) was applied from 7 to 21 d in culture. The number of neurons imaged is shown in parentheses for each bar in the graphs. Error bars areSEM, and p values are based on Student’s two-tailed
t test with unequal variance. **p	 0.01; ***p	 0.001. NS, Not significant.
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In contrast to XBP1, ATF6 showed a distinct nuclear local-
ization of fluorescence under baseline conditions (Fig. 4A).
When compared to untreated cells, nicotine (200 nM from 7 to
21 d in culture) significantly reduced nuclear ATF6 by12%,
with no effect on cytoplasmic ATF6 fluorescence (Fig. 4D).
Surprisingly, treatment of DA cultures with 50 nM Tu for 48 h
failed to upregulate ATF6 fluorescence in the nucleus or the
cytoplasm (Fig. 4E), and nicotine pretreatment did not affect
nuclear or cytoplasmic ATF6 following 48 h exposure to 50 nM
Tu (Fig. 4E). To induce a robust ER stress response with ATF6,
we exposed DA neurons to a 20-fold higher concentration of
Tu (1 M) for 48 h. One micromolar Tu-treated DA neurons
showed a significant 1.8-fold increase in nuclear and cyto-
plasmic ATF6 fluorescence compared to untreated control
cells (Fig. 4A,F ). Pretreatment with nicotine (200 nM from 7
to 21 d in culture) significantly inhibited Tu-induced upre-
gulation of nuclear and cytoplasmic ATF6 fluorescence
(Fig. 4F ).
These data show that smoking-relevant concentrations of nic-
otine attenuate the IRE1 and ATF6 signaling pathways in cul-
tured DA neurons. These are two arms of the UPR.
Chronic nicotine inhibits eIF2 phosphorylation in Tu-
stressed DA neurons
Because of an established role for eIF2 phosphorylation in
chronic ER stress and CHOP activation (Galehdar et al., 2010;
Colla et al., 2012a,b; Moreno et al., 2012; Mercado et al., 2013),
we assessed the effect of chronic nicotine on total and phosphor-
ylated eIF2 in the nucleus and cytoplasm of cultured DA neu-
rons. DA cultures were treated with nicotine (200 nM from 7 to
21 d in culture) and costained for either total or phosphorylated
eIF2. TH staining was used to identify DA neurons and to de-
marcate the nucleus and cytoplasm of cells (Fig. 5A). We ob-
served phosphorylated and total eIF2 fluorescence in the
nucleus and cytoplasm of TH and TH neurons (Fig. 5A) and
focused our studies on the TH (DA) neurons. Nicotine treat-
ment (200 nM from7 to 21 d in culture) did not affect nuclear and
cytoplasmic levels of either phosphorylated or total eIF2 in
TH neurons (Fig. 5B). Exposure of DA cultures to 50 nMTu for
72 h caused a significant increase in phosphorylated eIF2 fluo-
rescence in the cell nucleus and cytoplasm of TH neurons (Fig.
5C), whereas nicotine pretreatment (200 nM from 7 to 21 d in
culture) significantly inhibited the upregulation of phosphory-
lated eIF2 in the cell nucleus and cytoplasm of TH neurons
(Fig. 5C).
To assess whether the effects of nicotine on eIF2 were due
to a specific inhibition of phosphorylation or due to inhibition of
total eIF2 upregulation, we studied TH (DA) neurons coim-
munostained for total eIF2 (Fig. 5A). Similar to phosphorylated
eIF2, total eIF2 staining was observed in the nucleus and cy-
toplasm of TH neurons with cytoplasmic staining being10-
Figure 5. Nicotine inhibits Tu-induced phosphorylation of eIF2 in cultured DA neurons. A, Representative confocal images of DA neurons. Top two rows, Neurons treated with either DMSO or
Tu and stained for phosphorylated eIF2 (peIF2). Bottom, Neurons treatedwith DMSO and stained for total eIF2 (teIF2). Column labels indicate images with TH staining andmerged images.
B, Normalized baseline total and phosphorylated eIF2 fluorescencewith andwithout nicotine. C, Normalized phosphorylated eIF2 fluorescence following treatmentwith 50 nM Tu for 72 h, with
and without nicotine pretreatment. D, Normalized total eIF2 fluorescence following treatment with 50 nM Tu for 72 h, with and without nicotine pretreatment. For all graphs, drugs applied and
subcellular compartments (nucleus or cytoplasm) are shown on the x-axis. Nicotine (200 nM) was applied from 7 to 21 d in culture. The number of neurons imaged is shown in parentheses for each
bar in the graphs. Error bars areSEM, and p values are based on Student’s two-tailed t test with unequal variance. **p	 0.01; ***p	 0.001. NS, Not significant.
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fold brighter than nuclear fluorescence
(Fig. 5A). Tu (50 nM, 72 h) caused a sig-
nificant increase in total eIF2 within the
cell nucleus but failed to increase the cy-
toplasmic content of total eIF2 (Fig. 5D).
Compared to Tu-treated cells, nicotine
pretreatment (200 nM from 7 to 21 d in
culture) did not affect total eIF2 levels in
either the nucleus or the cytoplasm (Fig.
5D).
These data show that chronic nicotine
suppresses eIF2 phosphorylation in Tu-
stressedDAneurons in culture. This is the
third arm of the UPR pathway.
nAChRs are required for nicotine-
induced reduction in ER stress markers
We used cultured Neuro-2a cells to deter-
mine whether the presence of nAChRs
was required for nicotine-induced reduc-
tion in ER stressmarkers.We showed pre-
viously that Neuro-2a cells transiently
transfected with 42 nAChRs exhibit a
reduction in ATF6 nuclear translocation
following long-term treatment with 100
nM nicotine (Srinivasan et al., 2012). We
have now studied Neuro-2a cells trans-
fected with only ATF6-eGFP to determine
how ATF6 nuclear translocation, initi-
ated by 100 nM Tu, is altered by long-
term nicotine treatment (Fig. 6). We
observed that without nAChRs present, nicotine does not re-
duce ATF6 nuclear translocation.
TheNeuro-2a cell experiments also provided an opportunity for
pilot experiments on the omission of expression of either subunit
alone. Neuro-2a cells transfected with 4-mCherry subunits alone
displayed 1.25-fold (p	 0.05) elevation of ATF6 nuclear transloca-
tion, versus transfectionwith2alone.This shows thatunassembled
4 subunits, by themselves, evoke more ER stress than do unas-
sembled 2 subunits, even though either subunit is eventually de-
graded in the absenceof thepartner subunit (Whiteaker et al., 2006).
These observations are consistent with the observation that cells ef-
ficiently ubiquitinate, then proteolytically degrade, 2 subunits
(Rezvani et al., 2010). Inneither case (4alonenor2alone)was the
level of ER stress significantly changed by incubation with nicotine,
an unsurprising result because intact / subunit interfaces are re-
quired for nicotine binding.We therefore reasoned that2-subunit
knock-out cultures would contain unassembled 4 and/or 6 sub-
units, producing an artificially high level of ER stress, unsuitable for
our experiments.
We also reasoned that single 4 or 6 subunit knock-outs
would produce compensatory assembly of 2* nAChRs with the
remaining subunit, and/or changes in the level of 462
subunits (Zoli et al., 2002; Champtiaux et al., 2003), further com-
plicating the interpretation. We therefore generated and main-
tained a mouse strain that was homozygous null for both 4 and
6 nAChRs. We attempted to study embryonic cultures from
these mice. However, litters were rather small, vitiating system-
atic studies like those that we conducted on WT mice.
Thus, we cannot say whether the ER stress reduction by nico-
tine depends most on 42* or 62* nAChRs. Previous data in
transfected cell lines shows that nicotine exposure increases the
number of ER exit sites for both 42 and 623 nAChRs, and
this metric seems to correlate well with reduction of ER stress
(Srinivasan et al., 2011; Henderson et al., 2014).
Cultured DA neurons express 4*,6*, and3*
nAChR subunits
Midbrain DA neurons robustly express several nAChR subunits
in vivo (Schwartz et al., 1984; Clarke and Pert, 1985; Zoli et al.,
2002; Champtiaux et al., 2003); however the expression of
nAChRs in cultured DA neurons has not been characterized. We
usedmidbrain cultures fromhomozygous4-mCherry knock-in
and WT mice to assess 4 nAChR subunit expression in DA
cultures. Compared to WT cultures, we observed a significant
1.8-fold increase in direct mCherry fluorescence within the
somata of TH neurons at 5 and 10 d in culture (Fig. 7A,B). At
20 d in culture, there was a further 30% increase of 4-
mCherry fluorescence in TH neurons (Fig. 7B), and 99% of
THneurons showed4-mCherry fluorescence. To enhance the
detection of mCherry signals, we labeled 3-week-old 4-
mCherry knock-in and WT cultures with mCherry primary and
Alexa 555 secondary antibodies. Using this method, we observed
4-mCherry fluorescence in a subset of TH neurites from 4-
mCherry knock-in mice, whereas WT mice showed no signal in
TH neurons (Fig. 7C). TH neurons stained with mCherry
antibody showed an approximately fivefold greater mCherry flu-
orescence compared to neurons from WT cultures (Fig. 7D). In
addition, TH neurons showed a significant 2.6-fold greater
4-mCherry fluorescence compared to TH neurons from the
same cultures (Fig. 7D). This ratio is consistent with previous
reports that DA neurons express higher levels of 4* nAChRs
thanGABAergic neurons inmidbrain slices (Nashmi et al., 2007).
Previous work showed that 6* nAChRs are expressed in adult
mouseDAneurons, butnot inGABAergicneurons (Zoli et al., 2002;
Champtiaux et al., 2003; Drenan et al., 2008; Mackey et al., 2012),
Figure 6. In Neuro-2a cells not expressing nAChRs, nicotine induced no significant changes in nuclear versus cytoplasmic
localization of ATF6. A, Representative confocal images of Neuro-2a cells transfected alone with ATF6-eGFP were treated with no
drug, nicotine (100nM), Tu (100nM), or nicotinewithTu.B, NormalizedATF6-eGFPnuclear translocation. Thesedatawereanalyzed
with a one-way ANOVA and Tukey comparisons. n.s., Not significant.
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and this is confirmed by the RNA-Seq data presented in Table 1
(Trapnell et al., 2012); but it was important to know whether the
cultured DA neurons expressed the 6 subunit protein. We used
6-eGFP BAC transgenic mice (Mackey et al., 2012) to assess 6*
nAChR subunit expression in culturedDA neurons. The level of6
fluorescence inDAneuronswas lower than the4 signals, probably
because the embryonic cultures came from heterozygous 6-eGFP
crosses. (Attempts to generate homozygous6-eGFPmicewere un-
successful.) Therefore, we amplified the 6-eGFP fluorescence by
staining 3-week-old WT and 6-eGFP transgenic mouse cultures
with GFP primary and Alexa 488 secondary antibodies. eGFP im-
munofluorescence signalswere observed in the cell somata andneu-
rites of midbrain neurons from 6-eGFP mouse cultures, whereas
WT neurons showed a nonspecific background staining (Fig. 7E).
TheeGFPimmunofluorescencewasapproximatelyeightfoldgreater
than the nonspecific staining of WT neurons (Fig. 7F). Thus, cul-
turedDAneurons express nAChR subunits that traffic along neuro-
nal processes, with robust nAChR expression levels achieved at 3
weeks in culture.
The 6 and 3 nAChR subunit genes are adjacent, and many
6* nAChRs also contain the 3 subunit. We cultured 3-GFP
mouse ventral midbrain neurons to assess 3* nAChR subunit
expression in DA cultures. Immunostaining showed that 94%
of 3-GFP-positive neurons were TH positive (Fig. 7G). These
data confirm the presence of the 3 nAChR subunit in DA
neurons at 21 d.
Figure 7. Culturedmouse DA neurons express endogenous nAChR proteins. A, Representative confocal images of neurons from an4-mCherry knock-inmouse (two top panels) andWTmouse
(twobottompanels) immunostained for TH (two left panels) and imaged fordirectmCherry fluorescence (two rightpanels).B, NormalizeddirectmCherry fluorescence froman4-mCherry knock-in
mouse after 5, 10, or 20 d in culture compared to background fluorescence fromaWTmouse.C, Representative confocal images of4-mCherry knock-inmouse (two toppanels) andWTmouse (two
bottom panels) immunostained for TH andmCherry, showing the presence of4-mCherry fluorescence in a subset of TH neurites. D, Graph comparing mCherry fluorescence in TH and TH
neurons from an4-mCherry knock-in mouse after immunostaining with TH and mCherry antibodies. A WT mouse was also imaged to measure background mCherry staining. E, Representative
confocal images of neurons from an6-eGFP transgenic mouse (two top panels) and WT mouse (two bottom panels) immunostained for eGFP. The top left panel shows an eGFP neuron with
6-eGFP in the neurites, and the top right panel shows is a digital zoomof the eGFP cell body from the same neuron. Neurons fromWTmice (bottom two panels) shownonspecific eGFP staining.
F, Graph comparing eGFP fluorescence from6-eGFP transgenic mice to background eGFP staining inWTmice. Scale bars are indicated for each image. The number of neurons imaged is shown in
parentheses for each bar in the graphs. Error bars areSEM, and p values are based on Student’s two-tailed t test with unequal variance. ***p	 0.001. G, Immunostaining showed that 94% of
3-GFP-positive neuronswere TH positive (Fig. 6G). Nicotine (200 nM) was applied from days 7 to 21 in the nicotine-treated cultures. The number of DA neurons (TH and3-GFP) observed in
culture did not significantly change after nicotine treatment.
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Additionally, no significant difference was observed in the
number of DA neurons (as determined by TH staining) present
in control-treated versus nicotine-treatedWTmidbrain cultures.
Nicotine-treated cultures had no significant increase in WT DA
neurons compared to control cultures.
The 4-mCherry knock-in, 3-GFP knock-in, and 6-eGFP
BAC transgenic mouse lines thus served their purpose of identi-
fying some nAChR subunits in TH neurons. These lines were
not used for the electrophysiological experiments described in
Figure 9.
Cultured DA neurons express several DA-related mRNAs
In addition to the presence of nAChR receptor subunit proteins,
we asked which DA-related genes are expressed in the TH neu-
rons. We previously developed methods to obtain RNA-Seq data
from single neurons in our ventral midbrain cultures (Henley et
al., 2013). To extend the usefulness of such data, we cultured
ventral midbrain from BAC transgenic mice driving TH-eGFP
from the TH promoter, and we performed single-cell RNA-Seq
on eGFP-labeled neurons. We found coexpression of TH and
otherDA-related gene transcripts, including dopa decarboxylase,
the dopamine transporter DAT (slc6a3), and the dopamine D2
receptor, in addition to 4, 6, 2, and 3 nAChR subunit
mRNAs, in 100% of the TH-eGFP cells analyzed (Table 1). At the
single-cell level, the population of TH-positive neurons is con-
gruent with the population of neurons expressing other DA-
related genes.
This congruence prompted us to analyze other aspects of
gene expression in the TH-eGFP neurons. Many neuronal cell
types express the 7 nAChR subunit. 7 mRNA was expressed
at 1 fragments per kilobase per million mapped reads
(FPKM; at 16.14 FPKM) in only one of the seven TH-eGFP
cells analyzed.
Hyperpolarization-activated cyclic nucleotide-gated (HCN)
cation channels are encoded by the Hcn1-4 gene family. These
channels conduct an inward, excitatory current, Ih, acting as a
pacemaker current to initiate rhythmic firing, dampen dendritic
excitability, and regulate presynaptic neurotransmitter release
(He et al., 2014). Although the presence or absence of Ih current
has been used widely to distinguish DA from non-DA neurons in
the midbrain, we asked whether the presence of HCN channel
transcripts are an absolute identifier of cultured DA neurons.
Our RNA-Seq data show that four of the seven single DA neu-
rons, grown for 21 d in culture, hadHcn3 gene transcript levels of
1 FPKM. Only one of the seven GABAergic single cells had
Hcn3 gene transcripts at 1 FPKM. One of the remaining
TH-eGFP single cell libraries contained the Hcn4 transcript at 1
FPKM. RNA-Seq data showed that Hcn1 and Hcn2 gene tran-
scripts were detected at 0 or 	1 FPKM in all of the DA and
GABAergic neurons. In summary, five of the seven DA neurons,
but only one GABAergic neuron, contained Hcn transcripts at
1 FPKM. These data indicate that the Hcn3 transcript may be a
marker for, but not an absolute identifier of, DA neurons grown
for 21 d in culture.
nAChRs in cultured DA neurons functionally upregulate with
chronic nicotine
Cells morphologically identified as neurons were patch clamped
(Fig. 8A), and spontaneous APs were recorded in current-clamp
mode.We observed two spontaneous firing rates: 1 to 4Hz, often
associated with DA neurons, and10 Hz, often associated with
GABAergic interneurons (Fig. 8B). Neurons firing at 1 to 4 Hz
displayed Ih in response to 20 mV hyperpolarizing steps,
whereas Ih was not observed in neurons with a10Hz firing rate
(Fig. 8B). A study by Chieng et al. (2011) concluded that Ih cur-
rents can strengthen the classification, but are not sufficient to
reliably classify DA neurons. The RNA-Seq data presented above
confirm this ambiguity.
Previous studies (Chieng et al., 2011) suggest that the most
reliable electrophysiological criterion for DA neurons is the du-
ration of the APwaveform. This finding also holds for neurons in
the ventral tegmentum (Ford et al., 2006). The width of APs in
our putative cultured DA neurons was 40 to 50% greater than
GABAergic APs (Fig. 8C). The presence of TH as observed in our
immunocytochemistry studies (Fig. 1), spontaneous firing at 1 to
4 Hz, broad APs, and Ih currents (Drenan et al., 2008) suggest the
presence of DA neurons in the ventral midbrain cultures.
We assessed whether the nAChR subunits expressed by cul-
tured WT DA neurons form functional nAChRs. Neurons from
3-week-old WT ventral midbrain cultures were patch clamped
and assigned to putative DA versus GABAergic phenotypes based
on spontaneous firing rates and the presence or absence of Ih. A
200 ms puff of 300 M ACh elicited inward currents in 9 of 12
identified putative DA neurons (Fig. 9A, black trace). The decay
of the waveforms was probably shaped by both desensitization
and diffusion of the ACh. In preliminary experiments on un-
treated cultures, we found that 60% of the ACh response was
blocked by exposure to -conotoxin (CTX) MII (80 nM). This
is greater than the -conotoxin MII fraction in adult DA neu-
rons (Xiao et al., 2009). In contrast, only two of seven (28%)
GABAergic neurons responded to ACh (Fig. 9B); the re-
sponses were too small and too rare for systematic study.
We testedwhether chronic nicotine exposure functionally up-
regulates native nAChRs in putative DA neurons. We chose the
smoking-relevant nicotine dose of 200 nM (Matta et al., 2007)
used for ER stress experiments reported above; we exposed ven-
tral midbrain neurons to nicotine from days 7 to 21 in culture.
Responses to 200 ms puffs of 300 M ACh were recorded (Fig.
9A). Chronic low-dose nicotine exposure caused a significant
2.4-fold increase in ACh current amplitudes (p 	 0.05) when
compared to untreated cells (Fig. 9A,C). The 6*-selective an-
tagonist -conotoxinMII revealed that 4(non-6)* nAChRs in















chrna6 (6) 229.6 0.07
chrna4 (4) 20.9 26.35
chrnb2 (2) 9.1 17.26




RNA-Seq data for TH-eGFP and negative neurons are shown. Single cells were harvested on culture day 21 by
aspirating a single neuron from primary midbrain cultures into a glass pipette. The resultant mRNAs were reverse
transcribed and amplified to construct a single-neuronhigh-yield cDNA sequencing library. RNA-Seqdata show that
DA neurons had high levels of DA-related gene transcripts, including TH, dopa decarboxylase (DDC), dopamine
transporter DAT (slc6a3), and nAChR transcripts. However, these cells had low levels of the GABAergic marker
gene glutamic acid decarboxylase 1 (Gad1) and the serotonin 5-HT3 receptor A and B subunits (Htr3A and
Htr3B). GABAergic neurons have low to no levels of DA-related gene transcripts, chrna6, chrnb3, and Htr3A/B, but
havehigh levels of Gad1. RNA-Seq (Cuffdiff) data (Trapnell et al., 2012) are shown for dopamine-related, GABAergic,
nicotinic receptor, and serotonin transcripts.
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no-drug and nicotine-treated cultured DA neurons mediated
41.2 5.1% and 48.4 3.9% of the response, respectively (Fig.
9D–F).
In RNA-Seq data (Table 1), 4 signals are 10-fold lower
than 6 signals (21 vs 230 FPKM, respectively). Although RNA-
Seq data provide good comparisons of mRNA abundance when
comparedwithin a single gene and across conditions, we have less
confidence that RNA-Seq data reflect relative abundance of
nAChR subunitmRNAs across genes.We employ oligo-dTprim-
ers for cDNA synthesis, and this may introduce distortions for
brain mRNAs, which have long 3 untranslated regions. Further-
more, mRNA levels are not proportional to the level of protein
that is expressed on the cell surface. Translation efficiency and
protein half-life influence the correlation between mRNA and
protein abundances. We emphasize that the functional data pre-
sented in Figure 9,D–F, show4* and6* nAChRs eachmediate
Figure8. Electrophysiological characterization ofmouseDAneurons.A, Representative image of a 3-week-old culturedmouse ventralmidbrain neuron patch clamped forwhole-cell recordings.
The patch and puffer pipettes are shown. B, Two left graphs show spontaneous APs in current-clamped putative dopaminergic and GABAergic neurons. Two right-hand graphs show the presence
(putative dopaminergic) or absence (GABAergic) of Ih following successive20 mV hyperpolarizing steps. C, Average APs of cultured putative dopaminergic and GABAergic neurons are superim-
posed for a comparison of the spike width. The putative dopaminergic neuron AP is40% broader than the GABAergic AP.
Figure 9. Endogenously expressed nAChRs in cultured mouse putative DA neurons are functional and upregulate with chronic nicotine. A, Average waveforms of 300M ACh-evoked currents
from single trials in each of nine cultured putative DAneurons belonging to either untreated or nicotine treated groups (all neuronswith holding currents	250 pA are included in the average). ACh
pulse, 200 ms. Black trace, Neurons without nicotine pretreatment; red trace, neurons treated with 200 nM nicotine from 7 to 21 d in culture. Average holding currents were104 and85 pA
(saline- and nicotine-treated, respectively). The traces include a 5mVhyperpolarizing test pulse, showing that the neurons have roughly equal average input resistance of 0.3 G.B, Rare response
from an untreated GABAergic neuron following a 200ms puff of 300M ACh. C, Graph of average peak current amplitudes from all untreatedWT and nicotine-treatedWT putative DA neurons. D,
E, Averagewaveforms of 300MACh-evoked currents from single trials in putative DAneurons belonging to untreated (D) or nicotine-treated (E) groups before (black traces) and after (blue traces)
application of 80 nM-CTX MII. F, Percentage of control values from untreated and nicotine treated putative DA neurons following application of-CTX MII. In C and F, the number of neurons
measured is shown in parentheses for each bar. Error bars areSEM, and p values are based on Student’s two-tailed t test with unequal variance. *p	 0.05.
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50% of the ACh response, measured at the peak of the wave-
form, and this does not change markedly for the upregulated
responses.
In only one cell (a saline-treated putative DA neuron), the
waveform showed a rapidly desensitizing component (50–100
ms) that usually denotes 7 nAChRs (Xiao et al., 2009). In other
experiments with7-transfected cells, the instrumentation could
reliably detect such responses (Xiao et al., 2015). This observa-
tion, along with lack of robust 7 RNA-Seq signals, leads us to
believe that the ACh responses reflected primarily the activity of
42* and 62* rather than 7 nAChRs.
Discussion
Our data show that maintained exposure to a smoking-relevant
nicotine concentration attenuates mild ER stress and the UPR in
DA neurons (Figs. 3–5). Because most cases of PD progress over
decades, neurodegeneration occurs via comparatively subtle
pathophysiological processes. Rather than studying DA cell
death, we therefore studied events caused by a minimal cellular
stressor in long-term (three weeks) cultures of the mouse ventral
midbrain, containing DA neurons (Fig. 2). Because prolonged,
uncontrolled ER stress and the UPR are implicated in the patho-
genesis of PD (Hoozemans et al., 2007), our results suggest that
one neuroprotective mechanism for nicotine in DA neurons in-
volves suppression of the UPR.We demonstrate for the first time
that these culturedDAneurons express functional native4* and
6* nAChRs, as well as 3 subunits, a component of many 6*
nAChRs (Fig. 7). We also show, by using transfected neuroblas-
toma cells, that nAChRs are required for nicotine-induced reduc-
tion in ER stress markers (Fig. 6).
The simplified nature of a culture system allows one to suspect
that the effects occur in a cell-delimited fashion, independent of
circuit influences on the DA neurons, but we cannot yet rule out
indirect effects via nicotine actions on glia. Previous experiments
using expression of nAChRs in Neuro-2a cells and neurons show
that one such cell-delimited effect of low-dose nicotine is pharma-
cological chaperoning of nAChRs in the ER, leading to suppression
of ER stress and the UPR (Srinivasan et al., 2012). This suggestion
receives support because we observed an additional indicator of
pharmacological chaperoning by nicotine: the classical observation
that42* and some62* function is upregulated during chronic
exposure to nicotine (Henderson and Lester 2015).
Low-dose Tu induces, and nicotine suppresses, the UPR in
cultured DA neurons
We induced mild, prolonged ER stress by exposing WT cells to
Tu at a lower dose (50 nM) and for a longer time (72 h) than in
previous studies (Shiraishi et al., 2006; Han et al., 2008; Sasaya et
al., 2008; Bull andThiede, 2012). Tu (50 nM) induced the upregu-
lation and nuclear translocation of phosphorylated XBP1 (Fig.
4C) and eIF2 (Fig. 5), but failed to affect ATF6 (Fig. 4E). Tu (50
nM, 48 h) induced the upregulation and nuclear translocation of
CHOP,which is considered amajor apoptotic effector of theUPR
(Fig. 3). This suggests that ATF6 does not lie upstream of CHOP
activation in cultured DA neurons. Significant nuclear transloca-
tion of ATF6 did occur with a 20-fold higher concentration of Tu
(1 M for 48 h; Fig. 4F).
Baseline levels of XBP1, phosphorylated eIF2, and CHOP
were unaffected by a 2 week exposure to 200 nM nicotine (Figs.
3–5). Nicotine modestly reduced baseline levels of ATF6 in the
nucleus (Fig. 4D), suggesting that DA neurons may experience
mild, physiological ER stress due to cyclical Ca2 influx (Sur-
meier et al., 2011) and/or toxic metabolites of DA (Ahmadi et al.,
2008; Miyazaki and Asanuma, 2009).
Nicotine inhibited the Tu-induced upregulation and nuclear
translocation of XBP1, ATF6, and phosphorylated eIF2 (Figs. 4,
5). Thus, chronic nicotine at smoking-relevant concentrations,
acting via nAChRs, displays a global inhibitory effect on all arms
of the UPR pathway.
Which nAChR(s) participate in neuroprotection in
DA neurons?
Using three strains of mice with fluorescent nAChR subunits, we
found 4, 6, and 3 nAChR subunits in cultured DA neurons
and their neurites (Fig. 7). Responses to ACh indicated that the
endogenous nAChR receptor subunits do form functional het-
eropentamers (Fig. 9). Because 4* and 6* nAChRs require 2
subunits to form functional pentamers on the PM (Whiteaker et
al., 2006), we infer that the cultured DA neurons also express 2
subunits. Compared to DA neurons, TH-negative GABAergic
neurons (Fig. 9B) had few ACh responses; as expected, they had
no detectable 6 or 3 subunits.
In DA neurons, ACh-induced current waveforms (Fig. 9A)
and pharmacology show that the responses are generated pre-
dominantly by both 42* and 62* nAChRs, and not by 7
nAChRs. Chronic nicotine caused a more than twofold increase
in peak nAChR current amplitudes (Fig. 9A,C), a typical value in
the upregulation literature. Previous data on adult DA neurons
show that chronic exposure to nicotine upregulates somatoden-
dritic 6*nAChRs, but not somatodendritic 4* nAChRs
(Nashmi et al., 2007; Xiao et al., 2009; Henderson et al., 2014).
However, the similar effects of -CTX MII exposure on the un-
treated versus upregulated responses in cultured neurons (Fig.
9D–F) suggest that both 4* and 6* somatodendritic nAChRs
are upregulated.
RNA-Seq data from single neurons confirmed that cultured
DA neurons express 4, 6, 2, and 3 nAChR subunit mRNAs
(Henley et al., 2013). Our single-cell RNA-Seq data (Henley et al.,
2013; Table 1) show coexpression of TH and other DA-related
transcripts in addition to nAChR mRNAs in DA neurons.
Futureworkmay further specify the subtype(s) of nAChR that
subserve neuroprotection in culture. Adult DA neurons express
various nAChR subtypes in vivo, but this is the first study to
specify in vitro conditions that allow the expression andmeasure-
ment of so-called high-sensitivity nAChRs, presumably of the
42* and62* families, which are activated, desensitized, and
upregulated by smoking-relevant nicotine concentrations in DA
neurons. Other studies suggest that 42* and 62* nAChRs
are necessary for PDneuroprotection (Ryan et al., 2001;Quik and
Wonnacott, 2011). A study on apparent protection against Tu
effects by nicotine in PC12 cells found protection at non-
smoking-relevant concentrations of 50–500 M nicotine,100-
fold greater than the concentrations studied here (Sasaya et al.,
2008). This is consistentwith the knownpresence of7 and34
nAChRs, but of neither 4* nor 6* nAChRs, in PC12 cells.
Our ACh response waveforms and RNA-Seq data reveal little
or no contribution from7 nAChRs. Previous studies suggesting
involvement of 7 nAChRs in neuroprotection by nicotine have
used necrosis or apoptosis as an end point (Jonnala and Bucca-
fusco, 2001; Toulorge et al., 2011), rather than the present, more
subtle strategy of monitoring ER stress markers during ongoing
pathology in DA neurons. Thus, 7 may participate in the
final death of DA neurons rather than early pathological pro-
cesses in PD.
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Where is the “target” for nicotine neuroprotection in
DA neurons?
Nicotine’s possible neuroprotective mechanisms fall into two
major classes with regard to compartmentalization. “Outside-in”
mechanisms occur because nicotine activates nAChRs on the
plasma membrane, resulting in Ca2 influx and the initiation of
second messenger signaling cascades. Ca2-induced changes in
cellular transcription can partially explain the neuroprotective
effects of nicotine in DA neurons (Belluardo et al., 1999; Dajas-
Bailador et al., 2000; Mudo et al., 2007; Toulorge et al., 2011).
“Inside-out” mechanisms occur because, in addition to acti-
vating surface receptors, nicotine permeates the neuronal plasma
membrane and then enters the ER and other organelles in all cells
(Kuryatov et al., 2005; Sallette et al., 2005; Lester et al., 2009;
Miwa et al., 2011; Henderson and Lester 2015). In Neuro-2a cells
and in cortical neurons overexpressing nAChRs, this process at-
tenuates the UPR (Srinivasan et al., 2012); the present paper pro-
vides key support for the suggestion that similar processes occur
at endogenous nAChR levels. Consequent changes in nuclear
transcriptional processes might avert apoptotic ER stress re-
sponse pathways implicated in PD.
In the present experiments, nicotine inhibited the nuclear
translocation of CHOP, whereas the broad-spectrum nAChR
channel blocker, mecamylamine, failed to suppress this effect
(Fig. 3D). This is consistent with, but does not prove, an inside-
out mechanism, independent of plasma membrane nAChR acti-
vation. Another argument for inside-out mechanisms is that the
nicotine concentration (200 nM) studied here, which gave UPR
suppression and nAChR upregulation, is well below the EC50
value for most nAChRs, but above the EC50 value for pharmaco-
logical chaperoning by nicotine (Kuryatov et al., 2008).
Conceivably, processes in addition to pharmacological chap-
eroning participate in neuroprotection and/or upregulation. In
some heterologous expression systems, upregulation occurs via
decreased endocytosis from the plasma membrane as well as via
chaperoning (Kuryatov et al., 2005; Sallette et al., 2005; Rezvani et
al., 2010; Lomazzo et al., 2011; Srinivasan et al., 2011, 2012; Go-
vind et al., 2012;Henderson andLester 2015). Prolongednicotine
exposure at the plasma membrane induces high-affinity “desen-
sitized” nicotine-nAChR complexes, but there is no evidence that
plasmamembrane desensitization affects endoplasmic reticulum
stress, the unfolded protein response, upregulation, or neuropro-
tection (Henderson and Lester 2015).
Possible therapeutic advantages of exploiting high-sensitivity
native nAChRs
Previous authors suggested that therapeutic strategies to mini-
mize proapoptotic aspects of the UPR might be neuroprotective
during early-stage PD (Colla et al., 2012b). In addition to nico-
tine (a U.S. Food and Drug Administration approved drug) act-
ing on nAChRs, experimental compounds acting on other targets
have been investigated to suppress the UPR in neurons (Colla et
al., 2012b; Moreno et al., 2012; Sidrauski et al., 2013; Narayan et
al., 2014). Unfortunately, the targets studied, such as eIF2 and
PERK, are generally expressed in all cell types, and the homeo-
static UPR response is required for many aspects of normal func-
tion. Furthermore, salubrinal suppresses ER stress and delays the
onset of disease in an -synuclein overexpression mouse model
for PD, but exacerbates another neurodegenerative disease
model, prion-infected mice (Moreno et al., 2012). In contrast,
inside-out effects of smoking, nicotine patches, or vaping occur
only in neuronal cell types expressing high-sensitivity nAChRs,
and for incompletely understood reasons, in only a subset of
those (Henderson and Lester 2015). Thus, exploiting nAChRs to
minimize ER stress in PD may have the advantage of cellular
selectivity.
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